The Silent Revolution: How AI is Decoding the "Language of Antibodies" for Next-Gen Therapeutics
In the fast-evolving landscape of biopharmaceuticals, we are moving past the era of trial-and-error. If 2024 was the year Generative AI captured the public imagination, 2025-2026 is the era where AI delivers on its promise in the wet lab. Nowhere is this more evident than in antibody drug discovery—a field once hampered by years of "design-make-test" cycles, now being streamlined by...
0 Comments
0 Shares
94 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt